tiprankstipranks

Bradley Cole Insider Profile

4 Followers
Bradley Cole, CFO at Genomic Health, holds 19.31K shares in Castle Biosciences (Ticker: CSTL), holds 12.55K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 10.19K shares in Exact Sciences (Ticker: EXAS).
tipranks
Bradley Cole

Bradley Cole
Genomic Health (GHDX)
CFO

Ranked #57,114 out of 106,487 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-3.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
50.98%
27.36%
21.66%
A breakdown of Bradley Cole's holdings

Insider Roles

Exact Sciences
(EXAS)
General Manager - Diagnostics
Kiniksa Pharmaceuticals
(KNSA)
Director
Castle Biosciences
(CSTL)
Director
Roles that Bradley Cole holds in companies

Most Profitable Insider Trade

Stock:
Castle Biosciences
(CSTL)
Rating:Informative Sell
Date:Mar 09, 2026 - Today
Return:+5.40%
The most profitable trade made by Bradley Cole

Bradley Cole's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GHDX
Genomic Health
Nov 14, 2019
Uninformative Sell
$0.00
Exact Sciences
Feb 21, 2020
General Manager - Diagnostics
Uninformative Buy
620.78K
$1.07M
Castle Biosciences
Mar 09, 2026
Director
Uninformative Buy
16.05K
$454.34K
Kiniksa Pharmaceuticals
Jun 05, 2025
Director
Uninformative Buy
91.64K
$573.98K
List of latest transactions for each holding click on a transaction to see Bradley Cole's performance on stock

Bradley Cole insider profile FAQ

What is the percentage of profitable transactions made by Bradley Cole?
The percentage of profitable transactions made by Bradley Cole is 50%.
    What is the average return per transaction made by Bradley Cole?
    The average return per transaction made by Bradley Cole is -3.70%.
      What stocks does Bradley Cole hold?
      Bradley Cole holds: GHDX, EXAS, CSTL, KNSA stocks.
        What was Bradley Cole’s latest transaction?
        Bradley Cole latest transaction was an Uninformative Buy of $16.05K.
          What was Bradley Cole's most profitable transaction?
          Bradley Cole’s most profitable transaction was an Informative Sell of CSTL stock on March 9, 2026. The return on the trade was 5.40%.
            What is Bradley Cole's role in Genomic Health?
            Bradley Cole's role in Genomic Health is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.